Dr. Golan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Washington St
Nemc Box #836
Boston, MA 02111Phone+1 617-636-5000
Education & Training
Tufts Medical CenterFellowship, Infectious Disease, 1999 - 2002
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1990, MD
Certifications & Licensure
MA State Medical License 2001 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Clinical Trials
- Control of COVID-19 Outbreaks in Long Term Care Start of enrollment: 2020 Oct 16
Publications & Presentations
PubMed
- 31 citationsEfficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A...Dana M Cairns, Dorothy Dulko, Jeffrey K Griffiths, Yoav Golan, Theodora Cohen
JAMA Network Open. 2022-02-01 - 25 citationsFavipiravir in Patients With Early Mild-to-moderate Coronavirus Disease 2019 (COVID-19): A Randomized Controlled Trial.Yoav Golan, Jesus Abraham Simon Campos, Rob Woolson, Donald Cilla, Rodolfo Hanabergh
Clinical Infectious Diseases. 2023-02-08 - 44 citationsDual Antiviral Therapy for Persistent Coronavirus Disease 2019 and Associated Organizing Pneumonia in an Immunocompromised Host.Caitlin A Trottier, Beverly Wong, Rakhi Kohli, Cassidy Boomsma, Francis Magro
Clinical Infectious Diseases. 2023-03-04
Journal Articles
- Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab with Antibacterial Drug Treatment for Clostridium Difficile InfectionStephen Marcella, Yoav Golan, Clinical Infectious Diseases
Press Mentions
Study to Evaluate Favipiravir for COVID-19 Prevention and TreatmentSeptember 11th, 2020- Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2021August 14th, 2020
- Appili Therapeutics Announces FY 2020 Annual and Financial ResultsJune 24th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
